PTO Invalidates Novartis Unit's HIV Diagnostic Patent
In a blow to a Novartis AG subsidiary, the U.S. Patent and Trademark Office has issued a final interference decision striking down a patent covering technology for detecting HIV in the...To view the full article, register now.
Already a subscriber? Click here to view full article